103 related articles for article (PubMed ID: 12431031)
21. 1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activation.
Jain M; Kwon CH
J Med Chem; 2003 Dec; 46(25):5428-36. PubMed ID: 14640551
[TBL] [Abstract][Full Text] [Related]
22. Design of new oxazaphosphorine anticancer drugs.
Liang J; Huang M; Duan W; Yu XQ; Zhou S
Curr Pharm Des; 2007; 13(9):963-78. PubMed ID: 17430192
[TBL] [Abstract][Full Text] [Related]
23. [Clinical phase II trial of a new antineoplastic drug--glyciphosphoramide].
Sun Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Aug; 6(4):273-6. PubMed ID: 6241067
[No Abstract] [Full Text] [Related]
24. [Clinical phase II trial of a new antineoplastic drug, glyciphosphoramide (GPM)].
Sun Y
Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):375-8. PubMed ID: 6534723
[No Abstract] [Full Text] [Related]
25. Synthesis of phosphoramide mustard analogues of daunomycin and carminomycin.
Csorvási A; Kövér KE; Menyhárt MM; Sztaricskai F; Dobrynin YV; Nikolaeva TG
Arch Pharm (Weinheim); 1998 Sep; 331(9):265-8. PubMed ID: 9793480
[TBL] [Abstract][Full Text] [Related]
26. Determination of glufosfamide in rat plasma by liquid chromatography/tandem mass spectrometry.
Chen X; Sun Y; Cao X; Jin F; Zhong D
Rapid Commun Mass Spectrom; 2005; 19(13):1839-43. PubMed ID: 15945026
[TBL] [Abstract][Full Text] [Related]
27. Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.
Scheef W; Klein HO; Brock N; Burkert H; Günther U; Hoefer-Janker H; Mitrenga D; Schnitker J; Voigtmann R
Cancer Treat Rep; 1979 Mar; 63(3):501-5. PubMed ID: 106965
[TBL] [Abstract][Full Text] [Related]
28. [Clinical phase I trial of a new anti-neoplastic drug--glyciphosphoramide].
Sun Y
Zhonghua Zhong Liu Za Zhi; 1984 Jul; 6(4):293-5. PubMed ID: 6525950
[No Abstract] [Full Text] [Related]
29. Irofulven (MGI Pharma).
Baekelandt M
Curr Opin Investig Drugs; 2002 Oct; 3(10):1517-26. PubMed ID: 12431030
[TBL] [Abstract][Full Text] [Related]
30. Thymitaq (Zarix).
Niculescu-Duvaz I
Curr Opin Investig Drugs; 2001 May; 2(5):693-705. PubMed ID: 11569949
[TBL] [Abstract][Full Text] [Related]
31. High-dose intensity regimens with epirubicin in ovarian cancer.
Vermorken JB
Pathol Biol (Paris); 1992 Nov; 39(9):833. PubMed ID: 1538894
[No Abstract] [Full Text] [Related]
32. In vitro activity of oxazaphosphorines in childhood acute leukemia: preliminary report.
Styczyński J; Wysocki M; Debski R; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk J; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
Acta Biochim Pol; 2002; 49(1):221-5. PubMed ID: 12136944
[TBL] [Abstract][Full Text] [Related]
33. Chemical factors in the action of phosphoramidic mustard alkylating anticancer drugs: roles for computational chemistry.
Colvin ME; Sasaki JC; Tran NL
Curr Pharm Des; 1999 Aug; 5(8):645-63. PubMed ID: 10469896
[TBL] [Abstract][Full Text] [Related]
34. Laromustine, a sulfonyl hydrolyzing alkylating prodrug for cancer therapy.
Pigneux A
IDrugs; 2009 Jan; 12(1):39-53. PubMed ID: 19127504
[TBL] [Abstract][Full Text] [Related]
35. Flavopiridol. National Cancer Institute.
Wang HK
Curr Opin Investig Drugs; 2001 Aug; 2(8):1149-55. PubMed ID: 11892928
[TBL] [Abstract][Full Text] [Related]
36. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
Tsukamoto N; Chen J; Yoshida A
Blood Cells Mol Dis; 1998 Jun; 24(2):231-8. PubMed ID: 9714700
[TBL] [Abstract][Full Text] [Related]
37. Structure/activity studies with thiazolidinyl- and perhydrothiazinylphosphamide ester.
Voelcker G; Hohorst HJ
J Cancer Res Clin Oncol; 1998; 124(6):297-300. PubMed ID: 9692835
[TBL] [Abstract][Full Text] [Related]
38. Thermodynamic analysis of the reaction of phosphoramide mustard with protector thiols.
Seitz DE; Katterjohn CJ; Rinzel SM; Pearce HL
Cancer Res; 1989 Jul; 49(13):3525-8. PubMed ID: 2499418
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacology of cancer chemotherapy in children.
Evans WE; Petros WP; Relling MV; Crom WR; Madden T; Rodman JH; Sunderland M
Pediatr Clin North Am; 1989 Oct; 36(5):1199-230. PubMed ID: 2677939
[TBL] [Abstract][Full Text] [Related]
40. Miltefosine Zentaris.
Kaminsky R
Curr Opin Investig Drugs; 2002 Apr; 3(4):550-4. PubMed ID: 12090722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
